(March 13, 2020, 7:10 AM EDT) -- NEWARK, N.J. — A medical technology company and certain of its senior executives misrepresented and failed to disclose to investors design issues with one of its medical devices that led the company to lower its financial guidance for 2020 and engage in a costly remediation effort in violation of federal securities laws, an investor alleges in a Feb. 27 class action complaint filed in New Jersey federal court (Stephen Kabak v. Becton, Dickinson and Co., et al., No. 20-2155, D. N.J.)....